We use our own and third party cookies to offer you our services, customize and analyze your browsing and show you advertising related to your preferences. By continuing to browse, we consider that you accept its use. You can change the settings and get more information in the
Despite not being able to cure the disease, notable improvements in symptoms, exercise capacity and the quality of life of patients have been seen in recent years, due to the appearance of new drugs with specific action for pulmonary hypertension.
There are new lines of research of genetic studies and studies at the molecular level, which seek to understand and remedy the mechanisms responsible for the development of the disease.
Sorry this content wasn't helpful to you. Send us your comment and we will take it into account to continue improving.
Thanks for your help!
An error has occurred and we were unable to send your opinion, please try again later.
Substantiated information by:
Isabel Blanco Vich
Joan A. Barberà Mir
Published: 23 November 2021
Updated: 1 December 2021
The donations that can be done through this webpage are exclusively for the benefit of Hospital Clínic of Barcelona through Fundació Clínic per a la Recerca Biomèdica and not for BBVA Foundation, entity that collaborates with the project of PortalClínic.
Receive the latest updates related to this content.
Thank you for subscribing!
If this is the first time you subscribe you will receive a confirmation email, check your inbox
An error occurred and we were unable to send your data, please try again later.